NEW YORK, Nov. 30, 2016 /PRNewswire/ -- The Law Offices of
Vincent Wong announce that a class
action lawsuit has been commenced in the USDC for the District of
Massachusetts on behalf of
investors who purchased Biogen Inc. (NASDAQ: BIIB) securities
between July 23, 2014 and
July 23, 2015.
Click here to learn about the case:
http://www.wongesq.com/pslra/biogen-inc. There is no
cost or obligation to you.
According to the complaint, defendants employed devices, schemes
and artifices to defraud, while in possession of material adverse
non-public information, in an effort to assure investors of
Biogen's value and performance and continued substantial growth. In
particular, the complaint alleges that the Company failed to
disclose material information about the Company's business,
particularly in regards to their Tecfidera drug treatment.
In 2014, the MS Institute at Shepherd Center in Georgia, a prescriber of Tecfidera, began
conducting blood tests of MS patients taking the drug. By August of
that year, the Center began notifying Biogen that Tecfidera was
causing low lymphocyte counts among approximately 30% of the
Center's MS patients taking the drug; eventually the Center stopped
prescribing Tecfidera and transferred many of its patients to other
therapies. Biogen, however, continued to tout the safety and
growing sales of Tecfidera throughout the second and third quarter
of 2014.
If you suffered a loss in Biogen you have until December 23, 2016 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://www.wongesq.com/pslra/biogen-inc.
Vincent Wong, Esq. is an
experienced attorney that has represented investors in securities
litigations involving financial fraud and violations of shareholder
rights. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Logo - http://photos.prnewswire.com/prnh/20140904/143045
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biib-investor-alert-the-law-offices-of-vincent-wong-reminds-shareholders-of-a-class-action-involving-biogen-inc-and-a-lead-plaintiff-deadline-of-december-23-2016-300370565.html
SOURCE The Law Offices of Vincent
Wong